TrueBlue Clinical Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Hidradenitis suppurativa2 trials

Phase

• Phase 22 trials
• Phase 11 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Incyte Corporation3 trials
• Amgen1 trial
• Evommune, Inc.1 trial

Running trials

• Recruiting

  Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07213973· Phase 2· Incyte Corporation· Source

• Recruiting

  Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

  NCT07049575· Phase 1· Incyte Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa2 recruiting

Closed trials

• Completed

  Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

  NCT07150845· Phase 2· Evommune, Inc.· Source

• Terminated

  The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

  NCT05696392· Phase 4· Incyte Corporation· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source